Search research articles
Contact Us
Filters
Showing results (11-20 of 25) with videos related to
Page
of 3
Sort By:
BMC Biotechnology
|
March 18, 2018
Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equal
Rikki A M Brown, Michael R Epis, Jessica L Horsham, et al.
The International Journal of Biochemistry & Cell Biology
|
June 8, 2014
microRNA-7: a tumor suppressor miRNA with therapeutic potential
Felicity C Kalinowski, Rikki A M Brown, Clarissa Ganda, et al.
Blood
|
January 22, 2008
Erythroid defects in TRalpha-/- mice
Tulene S Kendrick, Christine J Payne, Michael R Epis, et al.
Plos One
|
November 2, 2012
Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7
Felicity C Kalinowski, Keith M Giles, Patrick A Candy, et al.
Scientific Reports
|
September 10, 2021
The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer
Dianne J Beveridge, Kirsty L Richardson, Michael R Epis, et al.
Biochemical and Biophysical Research Communications
|
September 25, 2012
Matrigel basement membrane matrix influences expression of microRNAs in cancer cell lines
Karina J Price, Anna Tsykin, Keith M Giles, et al.
Journal of Cellular Biochemistry
|
August 31, 2018
ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells
Jamie J Rodgers, Robert McClure, Michael R Epis, et al.
Journal of Biochemistry
|
February 28, 2012
Sequence requirements for RNA binding by HuR and AUF1
Andrew Barker, Michael R Epis, Corrine J Porter, et al.
The Journal of Biological Chemistry
|
June 22, 2005
The acute box cis-element in human heavy ferritin mRNA 5'-untranslated region is a unique translation enhancer that binds poly(C)-binding proteins
Andrew M Thomson, Catherine M Cahill, Hyun-Hee Cho, et al.
Oncotarget
|
September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression
Michael R Epis, Keith M Giles, Dianne J Beveridge, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 25) with videos related to
Sort By:
Page
of 3
BMC Biotechnology
|
March 18, 2018
Total RNA extraction from tissues for microRNA and target gene expression analysis: not all kits are created equal
Rikki A M Brown, Michael R Epis, Jessica L Horsham, et al.
The International Journal of Biochemistry & Cell Biology
|
June 8, 2014
microRNA-7: a tumor suppressor miRNA with therapeutic potential
Felicity C Kalinowski, Rikki A M Brown, Clarissa Ganda, et al.
Blood
|
January 22, 2008
Erythroid defects in TRalpha-/- mice
Tulene S Kendrick, Christine J Payne, Michael R Epis, et al.
Plos One
|
November 2, 2012
Regulation of epidermal growth factor receptor signaling and erlotinib sensitivity in head and neck cancer cells by miR-7
Felicity C Kalinowski, Keith M Giles, Patrick A Candy, et al.
Scientific Reports
|
September 10, 2021
The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer
Dianne J Beveridge, Kirsty L Richardson, Michael R Epis, et al.
Biochemical and Biophysical Research Communications
|
September 25, 2012
Matrigel basement membrane matrix influences expression of microRNAs in cancer cell lines
Karina J Price, Anna Tsykin, Keith M Giles, et al.
Journal of Cellular Biochemistry
|
August 31, 2018
ETS1 induces transforming growth factor β signaling and promotes epithelial-to-mesenchymal transition in prostate cancer cells
Jamie J Rodgers, Robert McClure, Michael R Epis, et al.
Journal of Biochemistry
|
February 28, 2012
Sequence requirements for RNA binding by HuR and AUF1
Andrew Barker, Michael R Epis, Corrine J Porter, et al.
The Journal of Biological Chemistry
|
June 22, 2005
The acute box cis-element in human heavy ferritin mRNA 5'-untranslated region is a unique translation enhancer that binds poly(C)-binding proteins
Andrew M Thomson, Catherine M Cahill, Hyun-Hee Cho, et al.
Oncotarget
|
September 15, 2017
miR-331-3p and Aurora Kinase inhibitor II co-treatment suppresses prostate cancer tumorigenesis and progression
Michael R Epis, Keith M Giles, Dianne J Beveridge, et al.
Page
of 3